Familial clustering of autoimmune diseases in patients with dilated cardiomyopathy

American Journal of Cardiology

Volumn 93, Issue 9, 2004, Pages 1189-1191

  Limas, Constantinos J ^a   Iakovis, Panayotis ^a   Anyfantakis, Alexandros ^a   Kroupis, Christos ^a   Cokkinos, Dennis V ^a  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLUSTER ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILIAL DISEASE; FEMALE; GENETIC RISK; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ADULT; AGED; AUTOIMMUNE DISEASES; CARDIOMYOPATHY, DILATED; CLUSTER ANALYSIS; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; RISK FACTORS; SOLUBILITY;

EID: 1942532125     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.01.060     Document Type: Article

References (21)

1. Shaw T., Elliot P., Mckenna W.J. Dilated cardiomyopathy a genetical heterogeneous disease. Lancet. 360:2002;654-655.
2. Caforio A.L., Bonifacia E., Stewart J.N., Neglia D., Parodi O., Bottazzo G.F., McKenna W.J. Novel organ-specific circulation cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol. 1:1990;1527-1534.
3. Furukawa Y., Kobuke K., Matsumori A. Role of cytokines in autoimmune myocarditis and cardiomyopathy. Autoimmunity. 34:2001;169-176.
4. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., Burnett J.C., Rodeheffer R.J., Chesebro J.H., Tazelaar H.D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 326:1992;77-87.
5. McKenna W.J., Codd M.B., McCann H.A., Sugrue D.D. Idiopathic dilated cardiomyopathy familial prevalence and HLA distribution. Heart. 77:1997;549-552.
6. Marriott J.B., Goldman J.H., Keeling P.J., Baig M.K., Dalgleish A.G., McKenna W.J. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart. 75:1996;287-290.
7. Caforio A.L.P., Keeling P.J., Zachara E., Mestroni L., Camerini F., Mann J.M., Bottazzo G.F., McKenna W.J. Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet. 344:1994;773-777.
8. Theze J., Alzari P.M., Bertoglio J. Interleukin 2 and its receptors results, advances, and new immunological functions. Immunol Today. 17:1996;481-486.
9. Limas C.J., Goldenberg I.F., Limas C. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy. Correlation with disease severity and cardiac autoantibodies. Circulation. 91:1995;631-634.
10. Mestroni L., Rocco C., Gregori D., Sinagra G., Di Lenarda A., Miocic S., Vatta M., Pinamonti B., Muntoni F., Caforio A.L., et al. Familial dilated cardiomyopathy evidence for genetic and phenotypic heterogeneity. J Am Coll Cardiol. 34:1999;181-190.
11. Ginn L.R., Lin J.P., Plotz P.H., Bale S.J., Wilder R.L., Mbauya A., Miller F.W. Familial autoimmunity in pedigrees of idiopathic inflammatory myopathy patients suggests common genetic risk factors for many autoimmune diseases. Arthritis Rheum. 41:1998;400-405.
12. Becker K.G., Simon R.M., Bailey-Wilson J.E., Freidlin B., Biddison W.E., McFarland H.F., Trent J.M. Clustering of non-major histocompatibility complex susceptibility candidate loci in human autoimmune diseases. Proc Natl Acad Sci USA. 95:1998;9979-9984.
13. Spence J.D., Norris J. Infection, inflammation, and atherosclerosis. Stroke. 34:2003;333-334.
14. Golbasi Z., Ucar O., Keles T., Sahin A., Cagli K., Camsari A., Diker E., Aydoglou S. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease evidence of ongoing inflammation. Eur J Heart Fail. 4:2002;593-595.
15. Lin J.P., Cash J.M., Doyle S.Z., Peden S., Kanik K., Amos C.I., Bale S.J., Wilder R.L. Familial clustering of rheumatoid arthritis with other autoimmune diseases. Hum Genet. 103:1998;475-482.
16. Limas C.J., Limas C., Goldenberg I.F., Blair R. Possible involvement of the HLA-DQB1 gene in susceptibility and resistance to human dilated cardiomyopathy. Am Heart J. 129:1995;1141-1144.
17. Limas C.J., Limas C., Kubo S.H., Olivari M.T. Anti-β-receptor antibodies in human dilated cardiomyopathy and correlation with HLA-DR antigens. Am J Cardiol. 65:1990;483-487.
18. Barrera P. Circulating interleukin-2 receptor (sIL-2R) levels in rheumatoid arthritis. Clin Immunol Immunopathol. 76:1995;102-104.
19. Veda H., Howson J.M.M., Esposito L. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:2003;506-511.
20. Limas C., Limas C.J., Boudoulas H., Graber H., Bair R., Sparks L., Wooley C.F. T-cell receptor gene polymorphisms in familial cardiomyopathy correlation with anti-β receptor autoantibodies. Am Heart J. 124:1992;1258-1263.
21. Danas E.M., Tsirogianni A., Kapou I., Karamitsos D., Economidou I., Dantis P.C. Serum IL-6, TNF-α, p55 sr TNF-α, p75sr TNF-α, sr IL-2α levels and disease activity in systemic lupus erythematosus. Clin Rheumatol. 18:1999;17-22.